Cyclo Therapeutics (CYTHW) had the highest return on January 2, 2024 by a US stock, returning 67.1%.

ASSET	DATE	% RETURN
Cyclo Therapeutics (CYTHW)	1/2/2024	67.08%
OneMedNet (ONMDW)	1/2/2024	66.67%
Revolution Medicines, Inc Warrant (RVMDW)	1/2/2024	60%
Dogness International Corp Class A (DOGZ)	1/2/2024	49.09%
NeoVolta Inc Warrant (NEOVW)	1/2/2024	46.55%
NRx Pharmaceuticals (NRXPW)	1/2/2024	46.3%
Horizon Space Acquisition I Corp Right (HSPOR)	1/2/2024	39.4%
Fusion Fuel Green (HTOOW)	1/2/2024	36.84%
Mediaco (MDIA)	1/2/2024	36.74%
Akso Health Group ADR (AHG)	1/2/2024	34.52%
TC BioPharm (Holdings) plc Warrants (TCBPW)	1/2/2024	33%
PolyPid (PYPD)	1/2/2024	32.93%
Volitionrx (VNRX)	1/2/2024	32.41%
DatChat (DATS)	1/2/2024	31.16%
Yoshiharu Global (YOSH)	1/2/2024	30.95%
Cingulate Inc Warrants (CINGW)	1/2/2024	30%
OncoCyte (OCX)	1/2/2024	28.4%
error (ZVZZT)	1/2/2024	28%
Forian (FORA)	1/2/2024	27.24%
Presidio Property Trust Inc Series A Common Stock Purchase Warrants (SQFTW)	1/2/2024	25.21%
Celularity (CELUW)	1/2/2024	25%
Taoping (TAOP)	1/2/2024	24.34%
WM Technology (MAPSW)	1/2/2024	24%
Bright Minds Biosciences (DRUG)	1/2/2024	23.42%
Hongli Group Inc Ordinary Shares (HLP)	1/2/2024	23.3%